Abstract

Impaired bone formation is the main characteristics of glucocorticoid (GC)-induced osteoporosis (GIO), which can be ameliorated by tanshinol, an aqueous polyphenol isolated from Salvia miltiorrhiza Bunge. However, the underlying mechanism is still not entirely clear. In the present study, we determined the parameters related to microstructure and function of bone tissue, bone microcirculation, and TXNIP signaling to investigate the beneficial effects of tanshinol on skeleton and its molecular mechanism in GIO rats. Male Sprague-Dawley rats aged 4 months were administrated orally with distilled water (Con), tanshinol (Tan, 25 mg kg−1 d−1), prednisone (GC, 5 mg kg−1 d−1) and GC plus tanshinol (GC + Tan) for 14 weeks. The results demonstrated that tanshinol played a significant preventive role in bone loss, impaired microstructure, dysfunction of bone metabolism and poor bone quality, based on analysis of correlative parameters acquired from the measurement by using Micro-CT, histomorphometry, ELISA and biomechanical assay. Tanshinol also showed a significant protective effect in bone microcirculation according to the evidence of microvascular perfusion imaging of cancellous bone in GIO rats, as well as the migration ability of human endothelial cells (EA.hy926, EA cells). Moreover, tanshinol also attenuated GC-elicited the activation of TXNIP signaling pathway, and simultaneously reversed the down-regulation of Wnt and VEGF pathway as manifested by using Western-blot method in GIO rats, EA cells, and human osteoblast-like MG63 cells (MG cells). Collectively, our data highlighted that tanshinol ameliorated poor bone health mediated by activation of TXNIP signaling via inhibiting microcirculation disturbance and the following impaired bone formation in GIO rats.

Highlights

  • Glucocorticoid (GC)-induced osteoporosis (GIO) is one of the most common secondary osteoporosis in clinical practice and may occur in people of all ages

  • The body weight of rats in the GC group kept slowly increasing compared with the Con group, but body weight of rats both in the Con group and the Tan group maintained at the highest level

  • To explore the protective effect of tanshinol on bone tissue of rats exposed to GC, we firstly scanned the cancellous bone by microCT and reconstructed the 3D-image of microstructure

Read more

Summary

Introduction

Glucocorticoid (GC)-induced osteoporosis (GIO) is one of the most common secondary osteoporosis in clinical practice and may occur in people of all ages. GIO is characterized by a marked impairment of bone formation, due to the decrease in osteoblast proliferation and activity (Taylor and Saag, 2019). The therapeutic strategy for GIO depends mainly on antiresorptive drugs used for the treatment of postmenopausal osteoporosis, its characteristic feature distinguished from GIO. Teriparatide was an unique bone anabolic drugs approved by FDA owing to stimulating osteogenesis (Taylor and Saag, 2019). More focuses on the new findings involving in bone metabolism may be beneficial for the research and development of novel therapeutic approach for GIO treatment

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call